The obtained results demonstrate that this anti-TM4SF5 monoclonal antibody has therapeutic effects in mouse models of colon cancer, and suggest that injection with anti-TM4SF5 antibody can be an efficacious therapeutics to treat colon cancer in humans. Here, TM4SF5 is linked to malignant colon neoplasm.